Cutaneous follicle center lymphoma, in remission is a type of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the skin. This condition is clinically significant as it can lead to skin lesions and systemic symptoms. The ICD-10 Code C82.6A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient outcomes.
ICD-10 Code C82.6A represents Cutaneous follicle center lymphoma, in remission, a subtype of follicular lymphoma that primarily affects the skin. This code is used when the patient has achieved remission, indicating that the disease is not currently active. It is essential for clinical documentation and billing to accurately reflect the patient's status and treatment history.
Cutaneous follicle center lymphoma, in remission is a malignancy of the skin originating from follicle center B-cells. The condition can progress from localized skin lesions to systemic involvement if not monitored and treated appropriately. Medical attention is crucial to manage symptoms and prevent recurrence.
ICD-10 Code C82.6A is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C82.6A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of Cutaneous follicle center lymphoma, in remission. This code is essential for ensuring continuity of care, supporting billing, and meeting EHR documentation standards.
Management of Cutaneous follicle center lymphoma, in remission focuses on monitoring and supportive care to maintain remission and prevent recurrence.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.6A is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description | 
|---|---|
| 99213 | Established patient office visit, moderate complexity. | 
| 11100 | Biopsy of skin, subcutaneous tissue, or mucous membrane. | 
| 96413 | Chemotherapy administration, intravenous, push technique. | 
Common Questions About Using ICD-10 Code C82.6A for Cutaneous follicle center lymphoma, in remission
What does it mean if a patient is in remission?
Being in remission means that the signs and symptoms of Cutaneous follicle center lymphoma are not currently present, indicating a positive response to treatment. Regular monitoring is essential to ensure that the condition does not recur.
How often should patients with this diagnosis be monitored?
Patients in remission from Cutaneous follicle center lymphoma should typically be monitored every 3 to 6 months, depending on individual risk factors and clinical judgment, to detect any signs of recurrence early.
Can Cutaneous follicle center lymphoma return after remission?
Yes, Cutaneous follicle center lymphoma can return after remission. Continuous follow-up and monitoring are crucial for early detection and management of any recurrence.
What are the common treatments for this condition?
Common treatments for Cutaneous follicle center lymphoma include topical therapies, systemic treatments, and regular dermatological assessments to manage symptoms and monitor for recurrence.
Clinical Notes
SOAP notes
DAP notes
AI medical notes